Literature DB >> 19631353

Effects of low- and high-glycemic index/glycemic load diets on coronary heart disease risk factors in overweight/obese men.

James M Shikany1, Radhika P Phadke, David T Redden, Barbara A Gower.   

Abstract

Chronic insulin resistance contributes to subclinical inflammation, thrombosis/impaired fibrinolysis, and dyslipidemia. The effect of dietary carbohydrate, specifically of glycemic index (GI) and glycemic load (GL), on established and emerging coronary heart disease risk factors has not been elucidated fully. We conducted a randomized crossover feeding study of matched diets differing only in GI and GL in 24 overweight or obese but otherwise healthy men to investigate the effects on insulin sensitivity, inflammation, thrombosis/fibrinolysis, lipoproteins/lipids, and body composition. All meals for the high- and low-GI/GL diets were prepared in a metabolic kitchen. Each participant consumed both diets in random order for 4 weeks each, with a 4-week washout period in between. Each participant underwent a frequently sampled intravenous glucose tolerance test for assessment of insulin sensitivity; blood sampling for the measurement of inflammatory markers, coagulation factors, and lipoproteins/lipids; and dual-energy x-ray absorptiometry for assessment of body composition at the beginning and end of each dietary period. There were no statistically significant differences in glucose metabolism factors, inflammatory markers, or coagulation factors after 4 weeks on the high- and low-GI/GL diets. The high-GI/GL diet resulted in a slightly greater reduction in fat mass and a slightly greater increase in lean mass compared with the low-GI/GL diet. The high-GI/GL diet resulted in significant, but unexpected, reductions in total and low-density lipoprotein cholesterol, whereas high-density lipoprotein cholesterol concentration was significantly reduced on the high-GI/GL diet compared with the low-GI/GL diet. Overall, high- and low-GI/GL diets of 4 weeks' duration had no consistent effects on coronary heart disease risk factors in this group of overweight/obese men.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631353      PMCID: PMC2936248          DOI: 10.1016/j.metabol.2009.06.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  37 in total

1.  Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men.

Authors:  Clara Bouché; Salwa W Rizkalla; Jing Luo; Hubert Vidal; Annie Veronese; Nathalie Pacher; Caroline Fouquet; Vincent Lang; Gérard Slama
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Glycemic index and disease.

Authors:  F Xavier Pi-Sunyer
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

4.  International table of glycemic index and glycemic load values: 2002.

Authors:  Kaye Foster-Powell; Susanna H A Holt; Janette C Brand-Miller
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

5.  A prospective randomised trial to determine the efficacy of a low glycaemic index diet given in addition to healthy eating and weight loss advice in patients with coronary heart disease.

Authors:  G S Frost; A E Brynes; C Bovill-Taylor; A Dornhorst
Journal:  Eur J Clin Nutr       Date:  2004-01       Impact factor: 4.016

Review 6.  Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.

Authors:  Paul M Ridker; Nancy J Brown; Douglas E Vaughan; David G Harrison; Jawahar L Mehta
Journal:  Circulation       Date:  2004-06-29       Impact factor: 29.690

Review 7.  Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease.

Authors:  T K Nordt; K Peter; J Ruef; W Kübler; C Bode
Journal:  Thromb Haemost       Date:  1999-09       Impact factor: 5.249

8.  C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.

Authors:  R Nesto
Journal:  Diabet Med       Date:  2004-08       Impact factor: 4.359

9.  Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein.

Authors:  Emily B Levitan; Nancy R Cook; Meir J Stampfer; Paul M Ridker; Kathryn M Rexrode; Julie E Buring; JoAnn E Manson; Simin Liu
Journal:  Metabolism       Date:  2008-03       Impact factor: 8.694

Review 10.  Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.

Authors:  A Mavri; M-C Alessi; I Juhan-Vague
Journal:  J Intern Med       Date:  2004-04       Impact factor: 8.989

View more
  16 in total

1.  Low-glycemic index diet may improve insulin sensitivity in obese children.

Authors:  Chonnikant Visuthranukul; Pathama Sirimongkol; Aree Prachansuwan; Chandhita Pruksananonda; Sirinuch Chomtho
Journal:  Pediatr Res       Date:  2015-08-13       Impact factor: 3.756

2.  The effect of an energy restricted low glycemic index diet on blood lipids, apolipoproteins and lipoprotein (a) among adolescent girls with excess weight: a randomized clinical trial.

Authors:  Mohammad Hossein Rouhani; Roya Kelishadi; Mahin Hashemipour; Ahmad Esmaillzadeh; Leila Azadbakht
Journal:  Lipids       Date:  2013-09-03       Impact factor: 1.880

3.  Dietary macronutrient composition affects β cell responsiveness but not insulin sensitivity.

Authors:  Laura Lee Goree; Paula Chandler-Laney; Amy C Ellis; Krista Casazza; Wesley M Granger; Barbara A Gower
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

4.  Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.

Authors:  Frank M Sacks; Vincent J Carey; Cheryl A M Anderson; Edgar R Miller; Trisha Copeland; Jeanne Charleston; Benjamin J Harshfield; Nancy Laranjo; Phyllis McCarron; Janis Swain; Karen White; Karen Yee; Lawrence J Appel
Journal:  JAMA       Date:  2014-12-17       Impact factor: 56.272

5.  The association of whole grain consumption with incident type 2 diabetes: the Women's Health Initiative Observational Study.

Authors:  Emily D Parker; Simin Liu; Linda Van Horn; Leslie F Tinker; James M Shikany; Charles B Eaton; Karen L Margolis
Journal:  Ann Epidemiol       Date:  2013-04-19       Impact factor: 3.797

6.  Small changes in glucose variability induced by low and high glycemic index diets are not associated with changes in β-cell function in adults with pre-diabetes.

Authors:  Kristina M Utzschneider; Tonya N Johnson; Kara L Breymeyer; Lisa Bettcher; Daniel Raftery; Katherine M Newton; Marian L Neuhouser
Journal:  J Diabetes Complications       Date:  2020-04-18       Impact factor: 2.852

Review 7.  Low glycaemic index diets for the prevention of cardiovascular disease.

Authors:  Christine Clar; Lena Al-Khudairy; Emma Loveman; Sarah Am Kelly; Louise Hartley; Nadine Flowers; Roberta Germanò; Gary Frost; Karen Rees
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

8.  Glycemic index and glycemic load and their association with C-reactive protein and incident type 2 diabetes.

Authors:  Geertruida J van Woudenbergh; Anneleen Kuijsten; Eric J G Sijbrands; Albert Hofman; Jacqueline C M Witteman; Edith J M Feskens
Journal:  J Nutr Metab       Date:  2011-05-05

9.  Application of Protein-Rich Oriental Diet in a community-based obesity control program.

Authors:  Nam-Seok Joo; Yong-Woo Park; Kyung-Hee Park; Chan-Won Kim; Bom-Taeck Kim
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

Review 10.  Starches, sugars and obesity.

Authors:  Erik E J G Aller; Itziar Abete; Arne Astrup; J Alfredo Martinez; Marleen A van Baak
Journal:  Nutrients       Date:  2011-03-14       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.